Gastrointestinal absorption of Tamiflu in critically ill patients with H1N1
Tuesday, February 16, 2010 - 15:14
in Health & Medicine
An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study in CMAJ (Canadian Medical Association Journal) .